Real-World Experience of Clascoterone Cream 1% in Acne Management: Case Series and Canadian Experience

    Elena Tay, Wei Jing Loo
    Studysummary This case series involving 10 patients treated with clascoterone cream 1% for acne vulgaris found it effective and well-tolerated, regardless of severity, age, gender, or ethnicity, and noted additional benefits for related skin conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dovepress.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Guidelines of Care for the Management of Acne Vulgaris Journal of the American Academy of Dermatology · 2024
    2. Use of Topical Clascoterone for the Treatment of Hidradenitis Suppurativa JAAD Case Reports · 2023
    3. Clascoterone as a Novel Treatment for Androgenetic Alopecia Clinical and Experimental Dermatology · 2020
    4. A Summary of In Vitro, Phase I, and Phase II Studies Evaluating the Mechanism of Action, Safety, and Efficacy of Clascoterone (Cortexolone 17a Propionate, CB-03-01) in Androgenetic Alopecia Journal of The American Academy of Dermatology · 2019
    5. Hormonal Treatment of Acne Vulgaris: An Update Clinical, Cosmetic and Investigational Dermatology · 2016